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Introduction
The Second International Conference of the African-Car-
ibbean Cancer Consortium (AC3) was held on May 12–
13, 2008 at the Wyndham Miami Airport Hotel & Execu-
tive Meeting Center in Miami, FL, USA. The conference
was organized by the University of Pittsburgh, Graduate
School of Public Health and the University of Pittsburgh
Cancer Institute.
The AC3 (http://www.ac-ca-consortium.org) was estab-
lished in 2006 for the study of viral, genetic, environmen-
tal, and lifestyle risk factors for cancer in populations of
African descent [1]. The goals of this year's conference
were to provide a forum for the Consortium members to
(1) share their research accomplishments (2) Identify
areas for further study and (3) build new collaborations.
There were 38 attendees that represented institutions from
various countries: The Bahamas; Barbados; Guyana;
Jamaica; Nigeria, Africa; Trinidad and Tobago; and the
United States (US). The attendees had an opportunity to
present their research either through oral or poster presen-
tations. Networking and further discussions were facili-
tated by question and answer periods after each
presentation as well as during the session breaks and din-
ner reception.
May 12, 2008
The conference began with the welcome and opening
presentation by Dr. Camille Ragin, the principal investiga-
tor of the AC3, who defined the AC3's purpose, goals, and
provided a brief overview of the membership status as
well as a summary of the ongoing AC3 research studies.
Currently there are 53 AC3 members many of whom are
conducting collaborative studies of cancer risk among
individuals of African descent. The AC3 is conducting col-
laborative studies on the etiology of cervical cancer in the
Bahamas, Tobago, Jamaica and US while studies in Guy-
ana and Nigeria are planned. Prostate cancer collabora-
tions have been established in the Bahamas, Jamaica,
Nigeria and US. Other collaborative studies that assess
cancer prevalence, screening, knowledge and perception
have also been established or are planned in Guyana, St.
Kitts/Nevis, St. Vincent, US Virgin Islands and the US.
Session I: Prostate Cancer and HHV8 Infections in 
Populations of African Descent
This first general session was chaired by Dr. Clareann Bun-
ker from the University of Pittsburgh, US and Dr. Robin
Roberts from the University of the West Indies, the Baha-
mas. The session was lead by a keynote presentation by
Dr. Folakemi Odedina of Florida A&M University, US,
entitled "Tracing the Root of Prostate Cancer Disparities
in Black Men: From West Africa to Caribbean Islands to
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United Kingdom". Dr. Odedina provided a brief history of
the Transatlantic Slave Trade, described how various pop-
ulations of African descent were connected worldwide.
She described the current status of prostate cancer research
in these populations, highlighting the limited knowledge
of prostate cancer burden in West African populations as
well as few research studies in African-Caribbean popula-
tions. The presentation ended with a charge that corre-
sponds with the primary goal of the AC3 project. In order
to address the prostate cancer disparity in Black men, col-
laborative studies with standardized methods and proto-
cols are needed in order to explore prostate cancer burden
and its risk factors among men of African ancestral origin
(African-Caribbean, African-American and African). Ses-
sion I continued with five additional short presentations
of research findings by AC3 members [2-6].
Session II: Cervical and Other HPV-Associated Cancers in 
Populations of African Descent
The second general session was chaired by Dr. Camille
Ragin from the University of Pittsburgh, US and Dr.
Norma McFarlane-Anderson from the University of the
West Indies, Jamaica. The keynote address was given by
Dr. Raleigh Butler from the University of the West Indies,
The Bahamas and was entitled: "Fact, Frictions and Frac-
tions, HPV the Bahamian Experience". Dr. Butler pre-
sented an overview of the Epidemiology of HPV and
related cancers and described the current status of this dis-
ease among Caribbean populations. Cervical cancer is the
second cause of cancer deaths in the Bahamas, and annual
cervical screening is performed in less than 10% of this at
risk population. Session II continued with four additional
presentations of human papillomavirus (HPV) related
studies conducted in Caribbean populations [7-10].
Day one of this conference concluded with two Special
Topics sessions. The first, "Sample Collection, Data Shar-
ing and Confidentiality" was facilitated by Dr. Emanuela
Taioli from the University of Pittsburgh. The participants
defined appropriate protocols for collection and storage
of data and samples as well discussed the importance of
standardization in multi-centered collaborative studies.
The second Special Topic, "Building Infrastructure for
Multi-Center Studies" was facilitated by Dr. Judith Jacob-
son from Columbia University. During this session the
participants discussed decisions and steps necessary for
obtaining funding and implementing a collaborative
study.
The day ended with a dynamic poster session and net-
working dinner reception, where the participants contin-
ued their discussions about their research projects and
reconnected with their colleagues and met new ones.
May 13, 2008
Session I: Breast Cancer in Populations of African Descent
This session was chaired by Dr. Michael Okobia, from the
University of Benin, Nigeria and Dr. Emanuela Taioli
from the University of Pittsburgh, US. Dr. Taioli launched
the session as the keynote speaker where she presented the
descriptive Epidemiology of Breast cancer among individ-
uals of African ancestry; discussed risk factors for this dis-
ease and identified the gaps in research for minority
populations. Dr. Taioli also presented some of her current
research findings from her studies of African American
populations. The session ended with three additional
research presentations by AC3 investigators [11-13].
The breast cancer session was followed by a Special Topic
discussion on Cancer Registration. There were presenta-
tions of cancer statistics by Ms. Veronica Roach from Dr.
Elizabeth Quamina Cancer Registry in Trinidad and Tobago
and Dr. Wallis Best-Plummer representing the Guyana
Cancer Registry in Guyana. The presenters provided data
from their corresponding cancer registry and were later
joined by Dr. Michael Okobia, from the University of
Benin, Nigeria for a panel discussion about the establish-
ment process of cancer registries and the challenges sur-
rounding cancer registration in developing countries.
The conference concluded with concurrent breakout ses-
sions where AC3 investigators divided into cancer-specific
working groups (cervical, breast and prostate). During
these sessions, AC3 investigators discussed the status of
the ongoing collaborative studies and defined future stud-
ies.
Conference evaluations
All participants were asked to complete evaluation forms
for both meeting dates and 95% of the forms were
returned. The majority of the participants (65%) reported
that, based on their prior knowledge, they learned more
after attending the cancer registration session. In general,
participants reported that the conference fulfilled their
reason for attending (73%). Eight-five percent were satis-
fied with the conference content, organization (81%),
and overall conference experience (85%).
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